Replies to post #84 on Abbott Laboratories (ABT)

[DewDiligence]

ABT ‘ReadMeFirst’ updated:

Humira hits primary endpoint in ulcerative colitis;
FDA approves ‘low volume’ Androgel;
bearish musings on TriCor/TriLipix from Forbes.

http://investorshub.advfn.com/boards/read_msg.aspx?message_id=63133115